Actively Recruiting
Genomic Sequencing in Anatomically Normal Fetuses
Led by University of California, San Francisco · Updated on 2026-04-08
1000
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.
CONDITIONS
Official Title
Genomic Sequencing in Anatomically Normal Fetuses
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant patients with a structurally normal fetus (singleton or multiple gestation)
- Planning to undergo prenatal diagnosis by chorionic villus sampling or amniocentesis with chromosome microarray analysis for routine reasons
- Planning, or have already completed, expanded carrier screening
You will not qualify if you...
- Decline prenatal diagnostic testing
- Pregnant with a fetus that has a known anomaly
- Declined chromosomal microarray analysis or expanded carrier screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, San Francisco
San Francisco, California, United States, 94143
Actively Recruiting
Research Team
N
Nuriye Sahin Hodoglugil, DrPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here